Methods Inf Med 2021; 60(05/06): 180-184
DOI: 10.1055/s-0041-1735169
Short Paper

The Acceptance of Interruptive Medication Alerts in an Electronic Decision Support System Differs between Different Alert Types

Janina A. Bittmann
1   Cooperation Unit Clinical Pharmacy, Heidelberg University Hospital, Heidelberg, Germany
2   Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany
,
Elisabeth K. Rein
1   Cooperation Unit Clinical Pharmacy, Heidelberg University Hospital, Heidelberg, Germany
2   Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany
,
Michael Metzner
2   Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany
,
Walter E. Haefeli
1   Cooperation Unit Clinical Pharmacy, Heidelberg University Hospital, Heidelberg, Germany
2   Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany
,
Hanna M. Seidling
1   Cooperation Unit Clinical Pharmacy, Heidelberg University Hospital, Heidelberg, Germany
2   Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany
› Author Affiliations
Funding None.

Abstract

Background Through targeted medication alerts, clinical decision support systems (CDSS) help users to identify medication errors such as disregarded drug–drug interactions (DDIs). Override rates of such alerts are high; however, they can be mitigated by alert tailoring or workflow-interrupting display of severe alerts that need active user acceptance or overriding. Yet, the extent to which the displayed alert interferes with the prescribers' workflow showed inconclusive impact on alert acceptance.

Objectives We aimed to assess whether and how often prescriptions were changed as a potential result of interruptive alerts on different (contraindicated) prescription constellations with particularly high risks for adverse drug events (ADEs).

Methods We retrospectively collected data of all interruptive alerts issued between March 2016 and August 2020 in the local CDSS (AiDKlinik) at Heidelberg University Hospital. The alert battery consisted of 31 distinct alerts for contraindicated DDI with simvastatin, potentially inappropriate medication for patients > 65 years (PIM, N = 14 drugs and 36 drug combinations), and contraindicated drugs in hyperkalemia (N = 5) that could be accepted or overridden giving a reason in free-text form.

Results In 935 prescribing sessions of 500 274 total sessions, at least one interruptive alert was fired. Of all interruptive alerts, about half of the sessions were evaluable whereof in total 57.5% (269 of 468 sessions) were accepted while 42.5% were overridden. The acceptance rate of interruptive alerts differed significantly depending on the alert type (p <0.0001), reaching 85.7% for DDI alerts (N = 185), 65.3% for contraindicated drugs in hyperkalemia (N = 98), and 25.1% for PIM alerts (N = 185).

Conclusion A total of 57.5% of the interruptive medication alerts with particularly high risks for ADE in our setting were accepted while the acceptance rate differed according to the alert type with contraindicated simvastatin DDI alerts being accepted most frequently.

Supplementary Material



Publication History

Received: 19 May 2021

Accepted: 12 July 2021

Article published online:
27 August 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Varghese J, Kleine M, Gessner SI, Sandmann S, Dugas M. Effects of computerized decision support system implementations on patient outcomes in inpatient care: a systematic review. J Am Med Inform Assoc 2018; 25 (05) 593-602
  • 2 Kuperman GJ, Bobb A, Payne TH. et al. Medication-related clinical decision support in computerized provider order entry systems: a review. J Am Med Inform Assoc 2007; 14 (01) 29-40
  • 3 Bertsche T, Pfaff J, Schiller P. et al. Prevention of adverse drug reactions in intensive care patients by personal intervention based on an electronic clinical decision support system. Intensive Care Med 2010; 36 (04) 665-672
  • 4 Bates DW, Teich JM, Lee J. et al. The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc 1999; 6 (04) 313-321
  • 5 Moja L, Kwag KH, Lytras T. et al. Effectiveness of computerized decision support systems linked to electronic health records: a systematic review and meta-analysis. Am J Public Health 2014; 104 (12) e12-e22
  • 6 Seidling HM, Klein U, Schaier M. et al. What, if all alerts were specific—estimating the potential impact on drug interaction alert burden. Int J Med Inform 2014; 83 (04) 285-291
  • 7 Jaspers MW, Smeulers M, Vermeulen H, Peute LW. Effects of clinical decision-support systems on practitioner performance and patient outcomes: a synthesis of high-quality systematic review findings. J Am Med Inform Assoc 2011; 18 (03) 327-334
  • 8 Salili AR, Hammann F, Taegtmeyer AB. Preventing adverse drug events using clinical decision support systems. Ther Umsch 2015; 72 (11-12): 693-700
  • 9 Carroll AE. Averting alert fatigue to prevent adverse drug reactions. JAMA 2019; 322 (07) 601
  • 10 van der Sijs H, Aarts J, Vulto A, Berg M. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc 2006; 13 (02) 138-147
  • 11 Kawamoto K, Houlihan CA, Balas EA, Lobach DF. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ 2005; 330 (7494): 765
  • 12 Dexheimer JW, Kirkendall ES, Kouril M. et al. The effects of medication alerts on prescriber response in a pediatric hospital. Appl Clin Inform 2017; 8 (02) 491-501
  • 13 Seidling HM, Phansalkar S, Seger DL. et al. Factors influencing alert acceptance: a novel approach for predicting the success of clinical decision support. J Am Med Inform Assoc 2011; 18 (04) 479-484
  • 14 Cornu P, Steurbaut S, Gentens K, Van de Velde R, Dupont AG. Pilot evaluation of an optimized context-specific drug-drug interaction alerting system: a controlled pre-post study. Int J Med Inform 2015; 84 (09) 617-629
  • 15 Ramirez M, Maranon R, Fu J. et al. Primary care provider adherence to an alert for intensification of diabetes blood pressure medications before and after the addition of a “chart closure” hard stop. J Am Med Inform Assoc 2018; 25 (09) 1167-1174
  • 16 Nanji KC, Seger DL, Slight SP. et al. Medication-related clinical decision support alert overrides in inpatients. J Am Med Inform Assoc 2017; 25 (05) 476-481
  • 17 Hussain MI, Reynolds TL, Zheng K. Medication safety alert fatigue may be reduced via interaction design and clinical role tailoring: a systematic review. J Am Med Inform Assoc 2019; 26 (10) 1141-1149
  • 18 Page N, Baysari MT, Westbrook JI. A systematic review of the effectiveness of interruptive medication prescribing alerts in hospital CPOE systems to change prescriber behavior and improve patient safety. Int J Med Inform 2017; 105: 22-30
  • 19 Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int 2010; 107 (31-32): 543-551
  • 20 O'Mahony D, O'Sullivan D, Byrne S, O'Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 2015; 44 (02) 213-218
  • 21 Shah NR, Seger AC, Seger DL. et al. Improving override rates for computerized prescribing alerts in ambulatory care. AMIA Annu Symp Proc 2005; 2005: 1110
  • 22 Radecki RP, McCoy AB, Sirajuddin AM, Murphy RE, Sittig DF. Effectiveness of bar coded medication alerts for elevated potassium. AMIA Annu Symp Proc 2012; 2012: 1360-1365